Guillain-Barré Syndrome after H1N1 Influenza: A Concern

Publisher： Karger

E-ISSN： 1423-0208|40|4|295-295

ISSN： 0251-5350

Source： Neuroepidemiology, Vol.40, Iss.4, 2013-03, pp. : 295-295

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Guillain-Barré Syndrome after H1N1 Vaccination in the United States: A Report Using the CDC/FDA Vaccine Adverse Event Reporting System (2009)

By  

Neuroepidemiology, Vol. 38, Iss. 4, 2012-04 ,pp. : 227-232

Karger

Access to resources Recommend Favorite

‘Hyperacute’ Guillain-Barré Syndrome

By  

European Neurology, Vol. 59, Iss. 1-2, 2007-10 ,pp. : 88-90

Karger

Access to resources Recommend Favorite

Successful Treatment of Guillain-Barré Syndrome with Combined Administration of Interferon-β-1a and Intravenous Immunoglobulin

By  

European Neurology, Vol. 46, Iss. 3, 2001-10 ,pp. : 167-168

Karger

Access to resources Recommend Favorite

The Epidemiology of Guillain-Barré Syndrome Worldwide

By  

Neuroepidemiology, Vol. 32, Iss. 2, 2008-12 ,pp. : 150-163

Karger

Access to resources Recommend Favorite

High Anti-GM1 and Anti-GD1a IgG Antibody Titers Are Detected in Guillain-Barré Syndrome but Not in Chronic Inflammatory Demyelinating Polyneuropathy

By  

European Neurology, Vol. 48, Iss. 2, 2002-08 ,pp. : 118-119

Karger

Access to resources Recommend Favorite